Diagnosis and Complications of Cushing's Syndrome: A Consensus Statement

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 12, 2003, Pages 5593-5602

  Arnaldi, G ^a,p   Angeli, A ^b   Atkinson, A B ^c   Bertagna, X ^d   Cavagnini, F ^e   Chrousos, G P ^f   Fava, G A ^g   Findling, J W ^h   Gaillard, R C ⁱ   Grossman, A B ^j   Kola, B ^a   Lacroix, A ^k   Mancini, T ^a   Mantero, F ^l   Newell Price, J ^m   Nieman, L K ^f   Sonino, N ^l   Vance, M L ⁿ   Giustina, A ^o   Boscaro, M ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY OF MILAN   (Italy)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^g UNIVERSITY OF BOLOGNA   (Italy)

^h ST LUKE S MEDICAL CENTER   (United States)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^k CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^l UNIVERSITY OF PADOVA   (Italy)

^m UNIVERSITY OF SHEFFIELD   (United Kingdom)

ⁿ UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^o UNIVERSITY OF BRESCIA   (Italy)

^p Clin Endocrinol Azienda O   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; DESMOPRESSIN; DEXAMETHASONE; GLUCOCORTICOID; GROWTH FACTOR; GROWTH HORMONE SECRETAGOGUE; HYDROCORTISONE; LOPERAMIDE;

ADRENAL CORTEX TUMOR; BLOOD SAMPLING; CIRCADIAN RHYTHM; CONFERENCE PAPER; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIFFERENTIAL DIAGNOSIS; GLUCOSE INTOLERANCE; HORMONAL REGULATION; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS GONAD SYSTEM; IMPAIRED GLUCOSE TOLERANCE; PRIORITY JOURNAL; REMISSION; SALIVARY GLAND; SCREENING TEST; URINALYSIS;

CARDIOVASCULAR DISEASES; COGNITION DISORDERS; CUSHING SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; MENTAL DISORDERS; OSTEOPOROSIS;

LEPTOSPIRA;

EID: 9144250366     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030871     Document Type: Conference Paper

References (76)

1. Orth DN 1995 Cushing's syndrome. N Engl J Med 332:791-803
2. Boscaro M, Barzon L, Fallo F, Sonino N 2001 Cushing's syndrome. Lancet 357:783-791
3. Bertagna X, Raux-Demay MC, Giulhaume B, Girard F, Luton JP 2002 Cushing's disease. In: Mehned S, ed. The pituitary. 2nd ed. Malden, MA: Blackwell; 592-612
4. Newell-Price J, Trainer P, Besser GM, Grossman AB 1998 The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19:647-672
5. Lacroix A, Ndiaye N, Tremblay J, Hamet P 2001 Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 22:75-110
6. Atkinson AB, Carson DJ, Hadden DR, Kennedy AL, Weaver JA, Sheridan B 1985 Five cases of cyclical Cushing's syndrome. Br Med J 29:1453-1457
7. Boscaro M, Barzon L, Sonino N 2000 The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings. Arch Intern Med 160: 3045-3053
8. Kaye TB, Crapo L 1990 The Cushing syndrome: an update on diagnostic tests. Ann Intern Med 112:434-444
9. Turpeinen U, Markkanen H, Valimaki M, Stenman UH 1997 Determination of urinary free cortisol by HPLC. Clin Chem 43:1386-1391
10. Findling JW, Raff H 1999 Newer diagnostic techniques and problems in Cushing's disease. Endocrinol Metab Clin North Am 28:191-210
11. Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B 1997 Evidence for the low dose dexamethasone suppression test to screen for Cushing's syndrome-recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem 34:222-229
12. Papanicolaou DA, Mullen N, Kyrou I, Nieman LK 2002 Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 87:4515-4521
13. Raff H, Raff JL, Findling JW 1998 Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab 83:2681-2686
14. Newell-Price JDC, Trainer PJ, Perry LA, Wass JAH, Grossman AB, Besser GMA 1995 Single sleeping midnight cortisol has 100% sensitivity for the diagnosis of Cushing's syndrome. Clin Endocrinol 43:545-550
15. Papanicolaou DA, Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1998 A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. J Clin Endocrinol Metab 83:1163-1167
16. Yanovski JA, Cutler Jr GB, Chrousos GP, Nieman LK 1993 Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. JAMA 269:2232-2238
17. Aron DC, Raff H, Findling JW 1997 Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 82:1780-1785
18. Newell-Price J, Morris DG, Drake WM, Korbonits M, Monson JP, Besser GM, Grossman AB 2002 Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 87:1640-1645
19. Nieman LK, Oldfield EH, Wesley R, Chrousos GP, Loriaux DL, Cutler Jr GB 1993 A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 77:1308-1312
20. Invitti C, Giraldi FP, de Martin M, Cavagnini F 1999 Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis. J Clin Endocrinol Metab 84:440-448
21. Tsagarakis S, Tsigos C, Vasiliou V, Tsiotra P, Kaskarelis J, Sotiropoulou C 2002 The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion. J Clin Endocrinol Metab 87:1646-1653
22. Moro M, Putignano P, Losa M, Invitti C, Maraschini C, Cavagnini F 2000 The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J Clin Endocrinol Metab 85:3569-3574
23. Colombo P, Dall'Asta C, Barbetta L, Re T, Passini E, Faglia G, Ambrosi B 2000 Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease. Eur J Endocrinol 143:227-234
24. Arvat E, Giordano R, Ramunni J, Arnaldi G, Colao A, Deghenghi R, Lombardi G, Mantero F, Camanni F, Ghigo E 1998 Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 83:4207-4211
25. Oldfield EH, Doppman JL, Nieman LK, Chrousos GP, Miller DL, Katz DA, Cutler Jr GB, Loriaux DL 1991 Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. N Engl J Med 325:897-905
26. Lienhardt A, Grossman AB, Dacie JE, Evanson J, Huebner A, Afshar F, Plowman PN, Besser GM, Savage MO 2001 Relative contributions of inferior petrosal sinus sampling and pituitary imaging in the investigation of children and adolescents with ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 86:5711-5714
27. Lamberts SW, de Herder WW, Krenning EP, Reubi JC 1994 A role of (labeled) somatostatin analogs in the differential diagnosis and treatment of Cushing's syndrome. J Clin Endocrinol Metab 78:17-19
28. Bochicchio D, Losa M, Buchfelder M 1995 Factors influencing the immediate and late outcome of Cushing's disease treated by transsphenoidal surgery: a retrospective study by the European Cushing's Disease Survey Group. J Clin Endocrinol Metab 80:3114-3120
29. Sonino N, Zielezny M, Fava GA, Fallo F, Boscaro M 1996 Risk factors and long-term outcome in pituitary-dependent Cushing's disease. J Clin Endocrinol Metab 81:2647-2652
30. Yap LB, Turner HE, Adams CB, Wass JA 2002 Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit. Clin Endocrinol (Oxf) 56:25-31
31. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF 2002 Long-term follow-up results of transsphenoidal surgery for Cushing's disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56:541-551
32. Chee GH, Mathias DB, James RA, Kendall-Taylor P 2001 Transsphenoidal pituitary surgery in Cushing's disease: can we predict outcome? Clin Endocrinol (Oxf) 54:617-626
33. McCance DR, Besser M, Atkinson AB 1996 Assessment of cure after transsphenoidal surgery for Cushing's disease. Clin Endocrinol 44:1-6
34. Atkinson AB, McCance DR, Kennedy L, Sheridan B 1992 Cyclical Cushing's syndrome first diagnosed after pituitary surgery: a trap for the unwary. Clin Endocrinol 36:297-300
35. Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL, Cutler GB 1987 The corricotropin releasing hormone test in the postoperative evaluation of patients with Cushing's syndrome. J Clin Endocrinol Metab 65:906-913
36. Etxabe J, Vazquez JA 1994 Morbidity and mortality in Cushing's disease: an epidemiological approach. Clin Endocrinol (Oxf) 40:479-484
37. Mantero F, Boscaro M 1992 Glucocorticoid-dependent hypertension. J Steroid Biochem Mol Biol 43:409-413
38. Magiakou MA, Mastorakos G, Zachman K, Chrousos GP 1997 Blood pressure in children and adolescents with Cushing's syndrome before and after surgical care. J Clin Endocrinol Metab 82:1734-1738
39. Fallo F, Budano S, Sonino N, Muiesan ML, Agabiti-Rosei E, Boscaro M 1994 Left ventricular structural characteristics in Cushing's syndrome. J Hum Hypertens 8:509-513
40. Fallo F, Paoletta A, Tona F, Boscaro M, Sonino N 1993 Response of hypertension to conventional antihypertensive treatment and/or steroidogenesis inhibitors in Cushing's syndrome. J Intern Med 234:595-598
41. Fallo F, Sonino N, Barzon L, Pistorello M, Fagotto U, Paoletta A, Boscaro M 1996 Effect of surgical treatment on hypertension in Cushing's syndrome. Am J Hypertens 9:77-80
42. Danese RD, Aron DC 1994 Cushing's syndrome and hypertension. Endocrinol Metab Clin North Am 23:299-324
43. Biering H, Knappe G, Gerl H, Lochs H 2000 Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 27:27-31
44. Melanson KJ, McInnis KJ, Rippe JM, Blackburn G, Wilson PF 2001 Obesity and cardiovascular disease risk: research update. Cardiol Rev 9:202-207
45. Taskinen MR, Nikkila EA, Pelkonen R, Sane T 1983 Plasma lipoproteins, lipolytic enzymes, and very low density lipoprotein triglyceride turnover in Cushing's syndrome. J Clin Endocrinol Metab 57:619-626
46. Friedman TC, Mastorakos G, Newman TD, Mullen NM, Horton EG, Costello R, Papadopoulos NM, Chrousos GP 1996 Carbohydrate and lipid metabolism in endogenous hypercortisolism: shared features with metabolic syndrome X and NIDDM. Endocr J 43:645-655
47. Boscaro M, Sonino N, Scarda A, Barzon L, Fallo F, Sartori MT, Patrassi GM, Girolami A 2002 Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome. J Clin Endocrinol Metab 87:3662-3666
48. Casonato A, Pontata E, Boscaro M, Sonino N, Sartorello F, Ferasin S, Girolami A 1999 Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. Blood Coagul Fibrinolysis 10:145-151
49. Colao A, Pivonello R, Spiezia S, Faggiano A, Ferone D, Filippella M, Marzullo P, Cerbone G, Siciliani M, Lombardi G 1999 Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84:2664-2672
50. Manelli F, Giustina A 2000 Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab 11:79-85
51. Kaltsas G, Manetti L, Grossman AB 2002 Osteoporosis in Cushing's syndrome. Front Horm Res 30:60-72
52. Leong GM, Mercado-Asis LB, Reynolds JC, Hill SC, Oldfield EH, Chrousos GP 1996 The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair. J Clin Endocrinol Metab 81:1905-1911
53. Canalis E, Giustina A 2001 Glucocorticoid-induced osteoporosis: summary of a workshop. J Clin Endocrinol Metab 86:5681-5685
54. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
55. Osella G, Terzolo M, Reimondo G, Piovesan A, Pia A, Termine A, Paccotti P, Angeli A 1997 Serum markers of bone and collagen turnover in patients with Cushing's syndrome and in subjects with adrenal incidentalomas. J Clin Endocrinol Metab 82:3303-3307
56. Rubin MR, Bilezikian JP 2002 Clinical review 151: the role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis - a reexamination of the evidence. J Clin Endocrinol Metab 87:4033-4041
57. Manning PJ, Evans MC, Reid IR 1992 Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf) 36:229-234
58. Di Somma C, Colao A, Pivonello R, Klain M, Faggiano A, Tripodi FS, Merola B, Salvatore M, Lombardi G 1998 Effectiveness of chronic treatment with alendronate in the osteoporosis of Cushing's disease. Clin Endocrinol (Oxf) 48:655-662
59. Lane NE, Sanchez S, Modin GW, Genant HK, Pierini E, Arnaud CD 2000 Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial. J Bone Miner Res 15:944-951
60. Sonino N, Fava GA 2001 Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment. CNS Drugs 15: 361-373
61. Dorn LD, Burgess ES, Dubbert B, Kling M, Gold PW, Chrousos GP 1995 Psychopathology in patients with endogenous Cushing syndrome: "atypical" or "melancholic" features. Clin Endocrinol (Oxf) 43:433-442
62. Magiakou MA, Mastorakos G, Oldfield EH, Gomez MT, Doppman JL, Cutler Jr GB, Nieman LK, Chrousos GP 1994 Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. N Engl J Med 331:629-636
63. Jeffcoate WJ, Silverstone JT, Edwards CR, Besser GM 1979 Psychiatric manifestations of Cushing's syndrome: response to lowering of plasma cortisol. Q J Med 48:465-472
64. Dorn LD, Burgess ES, Friedman TC, Dubbert B, Gold PW, Chrousos GP 1997 The longitudinal course of psychopathology in Cushing syndrome after correction of hypercortisolism. J Clin Endocrinol Metab 82:912-919
65. Bourdeau I, Bard C, Noel B, Leclerc I, Cordeau MP, Belair M, Lesage J, Lafontaine L, Lacroix A 2002 Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism. J Clin Endocrinol Metab 87:1949-1954
66. Forget H, Lacroix A, Cohen H 2002 Persistent cognitive impairment following surgical treatment of Cushing's syndrome. Psychoneuroendocrinology 27: 367-383
67. Giustina A, Wehrenberg WB 1992 The role of glucocorticoids in the regulation of growth hormone secretion. Trends Endocrinol Metab 3:306-311
68. Lebrethon MC, Grossman AB, Afshar F, Plowman PN, Besser GM, Savage MO 2000 Linear growth and final height after treatment for Cushing's disease in childhood. J Clin Endocrinol Metab 85:3262-3265
69. Magiakou MA, Mastorakos G, Chrousos GP 1994 Final stature in patients with endogenous Cushing syndrome. J Clin Endocrinol Metab 79:1082-1085
70. Feldt-Rasmussen U, Abs R, Bengtsson BA, Bennmarker H, Bramnert M, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, Wuster C 2002 KIMS International Study Board on behalf of KIMS Study Group. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. Eur J Endocrinol 146:67-74
71. Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB 2000 How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome? Clin Endocrinol 53:493-500
72. Lado-Abeal J, Rodriguez-Arnao J, Newell-Price JD, Perry LA, Grossman AB, Besser GM, Trainer PJ 1998 Menstrual abnormalities in women with Cushing's disease are correlated with hypercortisolemia rather than raised circulating androgen levels. J Clin Endocrinol Metab 83:3083-3088
73. Colao A, Pivonello R, Faggiano A, Filippella M, Ferone D, Di Somma C, Cerbone G, Marzullo P, Fenzi G, Lombardi G 2000 Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease. Clin Endocrinol 53:13-19
74. Stratakis C, Magiakou MA, Mastorakos G, Oldfield E, Chrousos GP 1997 Thyroid function in children with Cushing disease before and after transsphenoidal surgery. J Pediatr 131:905-909
75. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-644
76. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G, Angeli A 2002 Adrenal incidentaloma: a new cause of the metabolic syndrome? J Clin Endocrinol Metab 87:998-1003